A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
Victoria Ozberk(Griffith University), Manisha Pandey(Griffith University), Ainslie Calcutt(Griffith University), Michael F. Good(Griffith University), Emma L. Langshaw(Griffith University), Mehfuz Zaman(Griffith University), Jessica Dooley(Griffith University), Jamie‐Lee Mills(TAFE Queensland Gold Coast), Glen C. Ulett(Griffith University), Jacqualine Kaden(Griffith University), Sharareh Eskandari(University of Queensland), Yongbao Huo(Second Military Medical University), Michael R. Batzloff(Griffith University), Ailin Lepletier(Griffith University)
Cited by 19
Related Papers
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
|Advanced Drug Delivery Reviews|2016|370
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
|Immunity|2020|181
Hormonal control of T-cell development in health and disease
|Nature Reviews Endocrinology|2015|119
CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
|Cancer Immunology Research|2019|117